Daiichi Sankyo <4568.T>-2008/09 group results

May 12 (Reuters) -

DAIICHI SANKYO CO LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 842.15 880.12 960.00 465.00

(-4.3 pct) (-5.3 pct) (+14.0%) (+14.4%)
Operating 88.32 156.83 96.00 41.00

(-43.7 pct) (+15.0 pct) (+8.7%) (-33.5%)
Recurring 54.62 169.06 69.00 17.00

(-67.7 pct) (+11.2 pct) (+26.3%) (-71.5%)
Net loss 335.80 prft 97.66 prft 40.00 prft 8.00

(+24.3 pct) (-76.5%)
EPS loss Y474.05 prft Y135.35 prft Y56.82 prft Y11.36
EPS Y135.34
Annual div Y80.00 Y70.00 Y60.00
-Q2 div Y40.00 Y35.00 Y30.00
-Q4 div Y40.00 Y35.00 Y30.00

NOTE - Daiichi Sankyo Co Ltd is a holding company formed in Sept. 2005, through the union of two drug makers Sankyo and Daiichi Pharmaceutical..

For latest earnings estimates made by Toyo Keizai, please
double click on 4568.TK1.